Study shows clinical benefit of new way of treating advanced ER+ breast cancer

Enobosarm is a selective androgen receptor modulator which stimulates the male sex hormone receptor in oestrogen receptor positive breast cancer patients.

The drug was found to have anti-tumour effects, as well as being well tolerated with no significant impact on quality of life.